Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |